ASMTL | Acetylserotonin O-methyltransferase-like | | | | | | Expressed in all |
AKAP17A | A kinase (PRKA) anchor protein 17A | | | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ARSD | Arylsulfatase D | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Tissue enhanced |
CXorf28 | Chromosome X open reading frame 28 | | | | | | Tissue enhanced |
PRKX | Protein kinase, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
VCX3A | Variable charge, X-linked 3A | | | | | | Tissue enriched |
STS | Steroid sulfatase (microsomal), isozyme S | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
VCX | Variable charge, X-linked | | | | | | Tissue enriched |
PNPLA4 | Patatin-like phospholipase domain containing 4 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
VCX2 | Variable charge, X-linked 2 | | | | | | Tissue enriched |
VCX3B | Variable charge, X-linked 3B | | | | | | Tissue enriched |
TBL1X | Transducin (beta)-like 1X-linked | Plasma proteins
| | | | | Expressed in all |
GPR143 | G protein-coupled receptor 143 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MSL3 | Male-specific lethal 3 homolog (Drosophila) | Plasma proteins
| | | | | Expressed in all |
TLR7 | Toll-like receptor 7 | FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
FAM9C | Family with sequence similarity 9, member C | Predicted membrane proteins
| | | | | Tissue enriched |
TCEANC | Transcription elongation factor A (SII) N-terminal and central domain containing | | | | | | Mixed |
RAB9A | RAB9A, member RAS oncogene family | | | | | | Expressed in all |
OFD1 | Oral-facial-digital syndrome 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
GPM6B | Glycoprotein M6B | Predicted membrane proteins
| | | | | Tissue enriched |
GEMIN8 | Gem (nuclear organelle) associated protein 8 | | | | | | Expressed in all |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ASB9 | Ankyrin repeat and SOCS box containing 9 | | | | | | Tissue enhanced |
PIR | Pirin (iron-binding nuclear protein) | Enzymes Plasma proteins
| | | | | Expressed in all |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM27 | Transmembrane protein 27 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CA5B | Carbonic anhydrase VB, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
AP1S2 | Adaptor-related protein complex 1, sigma 2 subunit | Disease related genes
| | | | | Expressed in all |
S100G | S100 calcium binding protein G | | | | | | Tissue enriched |
SYAP1 | Synapse associated protein 1 | Predicted secreted proteins
| | | | | Expressed in all |
TXLNG | Taxilin gamma | | | | | | Expressed in all |
RBBP7 | Retinoblastoma binding protein 7 | | | | | | Expressed in all |
SCML1 | Sex comb on midleg-like 1 (Drosophila) | | | | | | Expressed in all |
BEND2 | BEN domain containing 2 | | | | | | Tissue enriched |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
PDHA1 | Pyruvate dehydrogenase (lipoamide) alpha 1 | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
SH3KBP1 | SH3-domain kinase binding protein 1 | Cytoskeleton related proteins
| | | | | Expressed in all |
RPS6KA3 | Ribosomal protein S6 kinase, 90kDa, polypeptide 3 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
YY2 | YY2 transcription factor | Transcription factors
| | | | | Tissue enhanced |
SMS | Spermine synthase | Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
PRDX4 | Peroxiredoxin 4 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ACOT9 | Acyl-CoA thioesterase 9 | Mitochondrial proteins
| | | | | Expressed in all |
KLHL15 | Kelch-like family member 15 | | | | | | Tissue enhanced |
EIF2S3 | Eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | Plasma proteins
| | | | | Expressed in all |
ZFX | Zinc finger protein, X-linked | Transcription factors
| | | | | Expressed in all |
POLA1 | Polymerase (DNA directed), alpha 1, catalytic subunit | Enzymes FDA approved drug targets
| | | | | Expressed in all |